{"author": "Li, JL ", "adress": "Chinese Acad Med Sci, Natl Clin Res Ctr Canc, Canc Hosp, Dept Med Oncol,Natl Canc Ctr, Beijing 100021, Peoples R China", "emails": ["lijunling@cicams.ac.cn"], "title": "Second-generation EGFR and ErbB tyrosine kinase inhibitors as first-line treatments for non-small cell lung cancer"}